A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00168402

Enrollment

193

Registered

2005-09-15

Start date

2002-02-28

Completion date

2005-10-31

Last updated

2011-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperhidrosis

Keywords

Axillary Hyperhidrosis

Brief summary

This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.

Interventions

DRUGBotulinum Toxin Type A

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* Marked axillary hyperhidrosis

Exclusion criteria

* Previous use of botulinum toxin for hyperhidrosis

Design outcomes

Primary

Measure	Time frame
Subject's assessment of the severity of hyperhidrosis	—

Secondary

Measure	Time frame
Measurement of axillary sweat production	—

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026